Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection

These Funding Opportunity Announcements (FOA) encourages research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer. These FOAs will promote rigor and reproducibility research in both the isolation of exosomes as well as the computational analysis of the cargo carried in these vesicles.

Read more about these FOAs:  PAR-16-276 and PAR-16-277

Funded Awards

  • Beth Israel Deaconess Medical Center
  • Cedars-Sinai Medical Center and Vanderbilt University
  • Cincinnati Children’s Hospital Medical Center
  • Northeastern University, Beth Israel Deaconess Medical Center
  • University of California, Los Angles
  • University of Texas MD Anderson Cancer Center
  • Weill Medical College of Cornell University

More about the Funded Awards

Publications

  • Belov et al., Electrophoresis 2018
  • Turzhistsky et al., Small 2018
  • Zhang et al. Nature Cell Biology 2018
  • Zhang, H. & Lyden, D. Nature Protocols. 14, (2019)

View Publications